Related Experiment Videos
Familial Bartter's syndrome: report of a case with early manifestations and persistent hypercalciuria
Helvetica Paediatrica Acta
|August 1, 1986
Insights
Familial Bartter's syndrome presents early and severely. Indomethacin managed prostaglandin issues but only partially corrected electrolyte losses, leading to high calcium levels during treatment.
Area of Science:
- Nephrology
- Pediatrics
- Endocrinology
Background:
- Familial Bartter's syndrome is a rare genetic disorder affecting kidney salt reabsorption.
- It leads to electrolyte imbalances, including hypokalemia and hypercalciuria, often presenting in infancy or childhood.
Observation:
- A case of familial Bartter's syndrome in a child with severe early-onset symptoms is described.
- The patient exhibited significant clinical and biochemical abnormalities consistent with the syndrome.
Findings:
- Indomethacin treatment successfully reduced elevated prostaglandin excretion.
- However, indomethacin only partially corrected potassium and calcium losses.
- Hypercalcemia developed during indomethacin therapy, accompanied by elevated parathyroid hormone and calcitriol levels.
Implications:
- This case highlights the complex management of familial Bartter's syndrome, particularly regarding electrolyte homeostasis.
- The development of hypercalcemia during indomethacin treatment suggests potential interactions with calcium-regulating hormones.
- Further research is needed to understand the long-term effects and optimal therapeutic strategies for this condition.
Abstract:
A case of familial Bartter's syndrome is reported. The child had early and severe clinical and biochemical manifestations. Indomethacin treatment effectively controlled the increased prostaglandin excretion but corrected only partially the potassium and the calcium losses. The child developed during treatment high serum calcium levels which were associated with high parathyroid hormone and calcitriol serum levels.